Solid forms of FXR agonists
US12102625B2 · kind B2 · utility
0Cited by
29References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2022 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Oct 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are novel solid forms of FXR agonists. The disclosure also relates to pharmaceutical compositions containing one or more of the solid forms disclosed herein, as well as methods of using the solid forms in the treatment of conditions mediated by FXR. The disclosure also relates to methods for obtaining such solid forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.